Defense World
21 Mar 2026, 05:14 UTC · 35w ago
Taysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up Following Better-Than-Expected Earnings
Impact · against what's priced in
Taysha Gene Therapies' better-than-expected earnings provide a positive short-term catalyst. The immediate price gap-up reflects the market adjusting to an improved bottom-line performance relative to expectations.
- TSHA+0.30
No priced-in read yet
- In context





